target and capturing

Latest paper on Affilin® technology published in Journal of Biological Chemistry

The latest scientific paper on the selection of new Affilin®-derived binding molecules, analytical data on their high affinity and specificity for the target extradomain B has been published by Scil Protein’s scientists on March 21 in the Journal of Biological Chemistry. The publication “Novel ubiquitin-derived high affinity binding proteins with tumor targeting properties” describes the in vivo tumor accumulation of Affilin®-based proteins in combination with several half-life extension technologies, further illustrating  the broad applicability of these proteins for different therapeutic approaches.